R.J. Rodgers - Publications, H-index & Citations

R.J. Rodgers

university of leeds

67H指数

271论文数

1.5W被引数

收录论文 33

发表时间

The within-subject application of diffusion tensor MRI and CLARITY reveals brain structural changes in Nrxn2 deletion mice

MOLECULAR AUTISM

IF5.5

2019-02-28

OAAI

Pervolaraki, Eleftheria; Tyson, Adam L.; Pibiri, Francesca; Poulter, Steven L.; Reichelt, Amy C.; Rodgers, R. John; Clapcote, Steven J.; Lever, Colin; Andreae, Laura C.; Dachtler, James

Missense mutation in DISC1 C-terminal coiled-coil has GSK3β signaling and sex-dependent behavioral effects in mice

SCIENTIFIC REPORTS

IF3.9

2016-01-05

OAAI

Dachtler, James; Elliott, Christina; Rodgers, R. John; Baillie, George S.; Clapcote, Steven J.

Deletion of α-neurexin II results in autism-related behaviors in mice

TRANSLATIONAL PSYCHIATRY

IF6.2

2014-11-25

OAAI

Dachtler, J.; Glasper, J.; Cohen, R. N.; Ivorra, J. L.; Swiffen, D. J.; Jackson, A. J.; Harte, M. K.; Rodgers, R. J.; Clapcote, S. J.

Pancreatic Islet Basement Membrane Loss and Remodeling After Mouse Islet Isolation and Transplantation: Impact for Allograft Rejection 小鼠胰岛隔离和移植后胰岛基底膜丢失和重塑: 对同种异体移植排斥反应的影响

CELL TRANSPLANTATION

IF3.2

2014-01-01

OAAI

Irving-Rodgers, H. F.; Choong, F. J.; Hummitzsch, K.; Parish, C. R.; Rodgers, R. J.; Simeonovic, C. J.

Anti-obesity drugs: past, present and future

DISEASE MODELS & MECHANISMS

IF3.3

2012-09-01

349

OAAI

Rodgers, R. John; Tschoep, Matthias H.; Wilding, John P. H.

The Obese Species: a special issue on obesity and metabolic disorders

DISEASE MODELS & MECHANISMS

IF3.3

2012-09-01

OAAI

Bartolomucci, Alessandro; Parmigiani, Stefano; Rodgers, R. John; Vidal-Puig, Antonio; Allan, Sarah E.; Siegel, Vivian

Behavioural satiety sequence (BSS) Separating wheat from chaff in the behavioural pharmacology of appetite

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2010-11-01

PREAI

Rodgers, R. J.; Holch, P.; Tallett, A. J.

Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2010-11-01

PREAI

Tallett, A. J.; Blundell, J. E.; Rodgers, R. J.

Studies of granulosa cell maturation in dominant and subordinate bovine follicles: novel extracellular matrix focimatrix is co-ordinately regulated with cholesterol side-chain cleavage CYP11A1

REPRODUCTION

IF3.7

2009-05-01

OAAI

Irving-Rodgers, H. F.; Harland, M. L.; Sullivan, T. R.; Rodgers, R. J.

Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2009-01-01

PREAI

Tallett, A. J.; Blundell, J. E.; Rodgers, R. J.

Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

IF2.5

2008-07-01

PREAI

Mathiasen, L. S.; Mirza, N. R.; Rodgers, R. J.

Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats

PSYCHOPHARMACOLOGY

IF3.3

2007-07-19

PREAI

Tallett, A. J.; Blundell, J. E.; Rodgers, R. J.

Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes

PSYCHOPHARMACOLOGY

IF3.3

2006-06-27

PREAI

Rodgers, R. J.; Augar, R.; Berryman, N.; Hansom, C. J.; O'Mahony, M. L.; Palmer, R. M.; Stevens, A.; Tallett, A. J.

Comparative cue generalization profiles of L-838,417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2006-03-01

PREAI

Mirza, NR; Rodgers, RJ; Mathiasen, LS

Comparative effects Of PYY3-36, CCK-8S and sibutramine on food intake, feeding behaviour and weight gain in rats

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2006-01-01

OAAI

Holch, P.; Rodgers, R. J.

Strain differences in the effects of GABAA receptor subtype selective compounds in the mouse light-dark test

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2006-01-01

PREAI

Mathiasen, L; Mirza, NR; Rodgers, RJ

PYY3-36 as an anti-obesity drug target

OBESITY REVIEWS

IF7.4

2005-10-20

104

PREAI

Boggiano, MM; Chandler, PC; Oswald, KD; Rodgers, RJ; Blundell, JE; Ishii, Y; Beattie, AH; Holch, P; Allison, DB; Schindler, M; Arndt, K; Rudolf, K; Mark, M; Schoelch, C; Joost, HG; Klaus, S; Thöne-Reineke, C; Benoit, SC; Seeley, RJ; Beck-Sickinger, AG; Koglin, N; Raun, K; Madsen, K; Wulff, BS; Stidsen, CE; Birringer, M; Kreuzer, OJ; Deng, XY; Whitcomb, DC; Halem, H; Taylor, J; Dong, J; Datta, R; Culler, M; Ortmann, S; Castañeda, TR; Tschöp, M

Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2003-01-01

PREAI

Holmes, A; Rodgers, RJ

Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline

GENES BRAIN AND BEHAVIOR

IF2.3

2002-10-17

PREAI

Rodgers, RJ; Davies, B; Shore, R